{"id":230493,"date":"2026-09-04T10:59:58","date_gmt":"2026-09-04T05:29:58","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=230493"},"modified":"2026-09-04T10:59:59","modified_gmt":"2026-09-04T05:29:59","slug":"is-medplus-health-services-a-good-buy-after-q1-fy27-results","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/is-medplus-health-services-a-good-buy-after-q1-fy27-results\/","title":{"rendered":"Is Medplus Health Services a Good Buy After Its Q1 FY27 Results?"},"content":{"rendered":"
<\/div>\n

Medplus Health Services share price around Rs 662. 35.2% below 52-week high of Rs 1,022. Q1 FY27 revenue Rs 1,899 crore, up 21.9% YoY. PAT Rs 33 crore, down 21.7%. PE 38x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Medplus Health Services’ Q1 FY27 results were mixed, with revenue at Rs 1,899 crore but PAT falling 22% to Rs 33 crore. The Medplus Health Services share price near Rs 662 has not escaped this pressure, and the profit decline is the key data point investors should weigh before deciding whether Medplus Health Services is a good buy right now.<\/p>\n<\/div>\n

The Medplus Health Services share price has been under the spotlight this results season after the company reported its first-quarter numbers for FY27. Medplus Health Services is one of India’s largest pharmacy retail chains, and its Q1 FY27 print, for the quarter ended June 30, 2026, gives investors a fresh data point to test whether the stock still deserves a place in a portfolio at current levels.<\/p>\n

Revenue for the quarter came in at Rs 1,899 crore, up 21.9% year on year, while profit after tax came in at Rs 33 crore, down 21.7% from a year earlier. That combination of numbers is exactly what this article breaks down, along with what it means for the Medplus Health Services share price from here.<\/p>\n

This piece works through the quarter’s financial highlights, the business factors behind the numbers, where the Medplus Health Services share price stands against its 52-week range and valuation multiples, and the key risks worth watching before treating this as a buy, hold or a stock to avoid for now.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n